| 1 | goal | 7,749 |
| 2 | rubric | 33 |
| 3 | photoreaction | 11 |
| 4 | self-ordered | 7 |
| 5 | bar-lab | 4 |
| 6 | professionalisation | 4 |
| 7 | celluloses | 3 |
| 8 | food-chain | 3 |
| 9 | i-care | 3 |
| 10 | qrgz-2h-8 | 3 |
| 11 | trigger/target | 3 |
| 12 | auto-ratio | 2 |
| 13 | crowning | 2 |
| 14 | gain/stable | 2 |
| 15 | low-tube-voltage/high-tube-current | 2 |
| 16 | social-class | 2 |
| 17 | t4-related | 2 |
| 18 | view-points | 2 |
| 19 | 0.025mg/ml | 1 |
| 20 | 1,5-diaryl-1,2,3-triazoles | 1 |
| 21 | 28.2°c | 1 |
| 22 | 48.95±11.80 | 1 |
| 23 | after-delivery | 1 |
| 24 | ak23-mediated | 1 |
| 25 | alignment/reduction | 1 |
| 26 | amidine-b | 1 |
| 27 | behavior-goal | 1 |
| 28 | c5-precursors | 1 |
| 29 | community-practice | 1 |
| 30 | congressionally | 1 |
| 31 | cyp102d1 | 1 |
| 32 | design/ | 1 |
| 33 | early-line | 1 |
| 34 | eruption/extrusion | 1 |
| 35 | exergonicities | 1 |
| 36 | healability | 1 |
| 37 | higher-dimension | 1 |
| 38 | individual-effects | 1 |
| 39 | instability/trophoblast | 1 |
| 40 | koln | 1 |
| 41 | mpfc-dependent | 1 |
| 42 | neaodjuvant | 1 |
| 43 | non-outbreak | 1 |
| 44 | organism-is | 1 |
| 45 | outpatient/home | 1 |
| 46 | phosphointeractome | 1 |
| 47 | placeboes | 1 |
| 48 | posttransplantion | 1 |
| 49 | predocetaxel | 1 |
| 50 | presentative | 1 |
| 51 | pt-pt | 1 |
| 52 | re-normalization | 1 |
| 53 | reduction.music | 1 |
| 54 | response-syllables | 1 |
| 55 | scientific/professional | 1 |
| 56 | side-advantage | 1 |
| 57 | situatioin | 1 |
| 58 | speciasl | 1 |
| 59 | standarisation | 1 |
| 60 | svr12-9 | 1 |
| 61 | target-pefrs | 1 |
| 62 | transmetalation/reductive | 1 |
| 63 | urban/peri-urban | 1 |
| 64 | z=1.442 | 1 |
| 65 | z=2.371 | 1 |
| 1 | 0.025mg/ml | 1 |
| 2 | 1,5-diaryl-1,2,3-triazoles | 1 |
| 3 | 28.2°c | 1 |
| 4 | 48.95±11.80 | 1 |
| 5 | after-delivery | 1 |
| 6 | ak23-mediated | 1 |
| 7 | alignment/reduction | 1 |
| 8 | amidine-b | 1 |
| 9 | auto-ratio | 2 |
| 10 | bar-lab | 4 |
| 11 | behavior-goal | 1 |
| 12 | c5-precursors | 1 |
| 13 | celluloses | 3 |
| 14 | community-practice | 1 |
| 15 | congressionally | 1 |
| 16 | crowning | 2 |
| 17 | cyp102d1 | 1 |
| 18 | design/ | 1 |
| 19 | early-line | 1 |
| 20 | eruption/extrusion | 1 |
| 21 | exergonicities | 1 |
| 22 | food-chain | 3 |
| 23 | gain/stable | 2 |
| 24 | goal | 7,749 |
| 25 | healability | 1 |
| 26 | higher-dimension | 1 |
| 27 | i-care | 3 |
| 28 | individual-effects | 1 |
| 29 | instability/trophoblast | 1 |
| 30 | koln | 1 |
| 31 | low-tube-voltage/high-tube-current | 2 |
| 32 | mpfc-dependent | 1 |
| 33 | neaodjuvant | 1 |
| 34 | non-outbreak | 1 |
| 35 | organism-is | 1 |
| 36 | outpatient/home | 1 |
| 37 | phosphointeractome | 1 |
| 38 | photoreaction | 11 |
| 39 | placeboes | 1 |
| 40 | posttransplantion | 1 |
| 41 | predocetaxel | 1 |
| 42 | presentative | 1 |
| 43 | professionalisation | 4 |
| 44 | pt-pt | 1 |
| 45 | qrgz-2h-8 | 3 |
| 46 | re-normalization | 1 |
| 47 | reduction.music | 1 |
| 48 | response-syllables | 1 |
| 49 | rubric | 33 |
| 50 | scientific/professional | 1 |
| 51 | self-ordered | 7 |
| 52 | side-advantage | 1 |
| 53 | situatioin | 1 |
| 54 | social-class | 2 |
| 55 | speciasl | 1 |
| 56 | standarisation | 1 |
| 57 | svr12-9 | 1 |
| 58 | t4-related | 2 |
| 59 | target-pefrs | 1 |
| 60 | transmetalation/reductive | 1 |
| 61 | trigger/target | 3 |
| 62 | urban/peri-urban | 1 |
| 63 | view-points | 2 |
| 64 | z=1.442 | 1 |
| 65 | z=2.371 | 1 |
| 1 | design/ | 1 |
| 2 | 48.95±11.80 | 1 |
| 3 | z=2.371 | 1 |
| 4 | cyp102d1 | 1 |
| 5 | z=1.442 | 1 |
| 6 | qrgz-2h-8 | 3 |
| 7 | svr12-9 | 1 |
| 8 | amidine-b | 1 |
| 9 | bar-lab | 4 |
| 10 | rubric | 33 |
| 11 | reduction.music | 1 |
| 12 | 28.2°c | 1 |
| 13 | self-ordered | 7 |
| 14 | ak23-mediated | 1 |
| 15 | t4-related | 2 |
| 16 | community-practice | 1 |
| 17 | side-advantage | 1 |
| 18 | gain/stable | 2 |
| 19 | outpatient/home | 1 |
| 20 | phosphointeractome | 1 |
| 21 | early-line | 1 |
| 22 | i-care | 3 |
| 23 | presentative | 1 |
| 24 | transmetalation/reductive | 1 |
| 25 | crowning | 2 |
| 26 | non-outbreak | 1 |
| 27 | scientific/professional | 1 |
| 28 | goal | 7,749 |
| 29 | behavior-goal | 1 |
| 30 | predocetaxel | 1 |
| 31 | 0.025mg/ml | 1 |
| 32 | speciasl | 1 |
| 33 | urban/peri-urban | 1 |
| 34 | food-chain | 3 |
| 35 | situatioin | 1 |
| 36 | koln | 1 |
| 37 | higher-dimension | 1 |
| 38 | eruption/extrusion | 1 |
| 39 | professionalisation | 4 |
| 40 | standarisation | 1 |
| 41 | re-normalization | 1 |
| 42 | photoreaction | 11 |
| 43 | alignment/reduction | 1 |
| 44 | posttransplantion | 1 |
| 45 | auto-ratio | 2 |
| 46 | exergonicities | 1 |
| 47 | response-syllables | 1 |
| 48 | 1,5-diaryl-1,2,3-triazoles | 1 |
| 49 | placeboes | 1 |
| 50 | celluloses | 3 |
| 51 | organism-is | 1 |
| 52 | target-pefrs | 1 |
| 53 | c5-precursors | 1 |
| 54 | social-class | 2 |
| 55 | individual-effects | 1 |
| 56 | view-points | 2 |
| 57 | trigger/target | 3 |
| 58 | neaodjuvant | 1 |
| 59 | mpfc-dependent | 1 |
| 60 | low-tube-voltage/high-tube-current | 2 |
| 61 | pt-pt | 1 |
| 62 | instability/trophoblast | 1 |
| 63 | congressionally | 1 |
| 64 | after-delivery | 1 |
| 65 | healability | 1 |